Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
09/2007
09/19/2007CN101037432A Preparation method of biochemistry method natural equivalent methyl acetyl raw alcohol dimmer aromatics
09/18/2007US7271296 phosphonium salt is condensed with an aldehyde in a Wittig reaction to give an acetal; the condensation product is subjected to an acid-catalyzed acetal hydrolysis to give an aldehyde which is condensed in a further Wittig reaction with a phosphonium salt to give phytofluene
09/18/2007US7271195 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
09/18/2007US7270856 contain both a CF2O bridge as constituent of their mesogenic skeleton and a butane-1,4-diyl group as part of a spiroalkane unit; Liquid-crystal display element, containing a dielectric, which dielectric is a liquid-crystalline medium comprising inventive compound
09/13/2007WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
09/12/2007EP1527064B1 Preparation of lactic acid derivatives and their use
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/11/2007CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers
09/07/2007WO2007057703B1 Intermediate compounds for the preparation of statins
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/05/2007EP1828161A2 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1368334B1 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101029041A Aryl-folinic phenol acetic acid and 1,4-dioxane complex, its production and use
09/05/2007CN100335484C Method for preparing neutral polyethyidenedioxythiophene and its correspondent compound
09/04/2007US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds
09/04/2007CA2242218C Process for preparing cyclobutane-1,2-dicarboxylic esters
08/2007
08/30/2007US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/29/2007EP1824808A1 Process for purifying hydroxycarboxylic acid, process for producing cyclic ester, and process for producing polylhydroxycaboxylic acid
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN100334081C 5-acrylic oxo-trimethylene carbonate and its preparation and use
08/28/2007US7262296 Substituted aryl alkenoic acid heterocyclic amides
08/28/2007US7262236 Dibenzylidenesorbitol derivatives made by condensation, acetalization, and cyclization of benzaldehyde derivative and mono-, di-, or tri-acetal substituted alditol; nucleating, gelling, or clarifying agents; thickeners; plastic and/or polypropylene additive
08/28/2007CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007US20070194278 1,3-Dioxane derivatives, composition, optical element and display device containing the same
08/22/2007EP1819691A2 Biaryloxymethylarene carboxylic acids
08/15/2007EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds
08/14/2007US7256289 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
08/14/2007US7256286 Bryostatins exhibit potent activity against a broad range of human cancer cell lines
08/14/2007US7256218 Biguanide and dihydrotriazine derivatives
08/09/2007US20070185057 Novel Indanone Compounds
08/08/2007EP1814870A2 Benzo-1,3-dioxanes for use in liquid crystal devices
08/08/2007EP1585742B1 Substituted benzoyl derivatives uses as herbicides
08/08/2007EP1554264B1 Medicinal arylethanolamine compounds
08/08/2007CN1330656C Chiral acetal and ketal compounds and their synthesis method and use
08/08/2007CN101014565A Diarylsulfones as 5-HT2a antagonists
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253185 Amino ceramide-like compounds and therapeutic methods of use
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
07/2007
07/31/2007US7250444 Pyrrole-based HMG-CoA reductase inhibitors
07/26/2007WO2007083640A1 Preventive or remedy for increased urinary frequency and urinary incontinence
07/26/2007WO2007057703A3 Intermediate compounds for the preparation of statins
07/26/2007US20070173660 Catalytic composition and process for asymmetric hydrogenation
07/26/2007US20070173542 Peptide deformylase inhibitors
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/25/2007EP1572628B1 Isophtalic acid derivatives
07/25/2007EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use
07/25/2007CN1328276C Method for preserving cyclic condensed formol
07/25/2007CN101006072A Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
07/25/2007CN101006071A Synthesis of polyoxygenated nitrogen systems, comprising reactions between enamines of 1,3-dioxan-5-ones and nitroolefins
07/19/2007US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
07/18/2007EP1807393A1 Diarylsulfones as 5-ht2a antagonists
07/18/2007CN101001849A Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
07/18/2007CN100999516A Purifying process of glycolide
07/18/2007CN100999515A Synthesizing process and use of unsaturation cyclic aliphatic carbonate monomer and its polymer
07/17/2007US7244853 Dioxanes and uses thereof
07/12/2007DE19624590B4 2,2-Difluor-1,3-dioxane, diese enthaltendes flüssigkristallines Medium, deren Verwendung und Zwischenprodukte (1,3-Dioxan-2-thione) 2,2-difluoro-1,3-dioxane, these liquid-crystalline medium containing, their use and intermediates (1,3-dioxan-2-thione)
07/11/2007EP1805159A1 Substituted carboxylic acids
07/11/2007EP1175398B1 Indoline derivatives as progesterone antagonists
07/11/2007CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives
07/11/2007CN1325456C Perfluoroallyloxy compound and liquid-crystal composition containing the compound
07/11/2007CN1325162C Catalyst for preparing p-cyclodexanone dioxide
07/10/2007US7241905 Screening kit; measuring decomposition of dioxin compound
07/05/2007WO2007074776A1 Method for purification of substances contaminated with organic chemicals
07/05/2007WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
07/04/2007EP1740653A4 Method of nucleating a polyolefin composition with acetal-based compounds
07/04/2007CN1993445A Photochromic materials
07/03/2007US7238461 contains a dye having at least two chromophores bonded to each other without any conjugated bond intervening between those chromophores; having a complex refractive index great in real part n and almost equal or small in imaginary part k
06/2007
06/27/2007EP1801104A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions
06/27/2007EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1986541A Resolving process of (RS)-benzdioxan-2-formic acid
06/27/2007CN1986540A Production process of alpha-hydroxy organic acid cyclic ester
06/27/2007CN1323082C Indicated tetraodotoxin, preparation and use thereof
06/27/2007CN1323081C Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
06/26/2007US7235673 heating within solvent, then distilling; hydrolysis; solution depolymerization
06/26/2007US7235663 E.g., 2,6-Diethyl-4,4-dimethoxy-2,3,6-trimethyl-1-(1-(4-oxir-anylmethoxy-phenyl) -ethoxy)-piperidine or 7,9-Diethyl-2,6, 7,9-tetramethyl-8-(1-(4-oxiranylmethoxy-phenyl)-ethoxy)-1,4-dioxa-8-aza -spiro(4.5)decane; anionic polymerization
06/21/2007WO2007069777A2 Fungicidal composition containing carboxylic acid amide derivative
06/21/2007WO2007069773A1 A pharmaceutical composition comprising an amide derivative
06/21/2007WO2007068330A1 2-ADAMANTYLUREA DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007CA2633186A1 2-adamantylurea derivatives as selective 11.beta.-hsd1 inhibitors
06/21/2007CA2631532A1 Fungicidal composition containing carboxylic acid amide derivative
06/21/2007CA2571640A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions
06/20/2007EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/20/2007CN1984949A Method of nucleating a polyolefin composition with acetal-based compounds
06/20/2007CN1982307A Process for synthesizing chiral N-aryl piperazines
06/19/2007US7232852 matrix resin for dental restorative materials; decreased shrinkage on on curing
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007EP1577286B1 Perfluoroallyloxy compound and liquid-crystal composition containing the compound
06/13/2007EP1574509B1 Process for the production of 1-acetoxy-3-(substituted phenyl)propenes
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 103